HPE & IHC Diagnostic Services
HPE & IHC Diagnostics Test
Immunohistochemistry (IHC) combines histological, immunological and biochemical techniques for the identification of specific tissue components by means of a specific antigen / antibody tagged with a visible label.
IHC & Histopathology
Histopathology, an important tool in anatomical pathology involves microscopic examination of histological sections of a biopsied specimen after the specimen after the specimen has been processed and have been placed onto glass slides. Study of biopsied tissue.
BIOGNOSYS is offering services in Immuno Histo Chemistry (IHC) and histopathology with unique reporting pattern in quick turnaround time.
HPE & IHC DIAGNOSTIC TESTS
| TEST CODE | HPE & IHC MARKER/PANEL | METHOD | SAMPLE |
|---|---|---|---|
| BGHP 301 | BIOPSY - BONE | HISTOPATHLOGY | F F TISSUE / F F P E BONE |
| BGHP 302 | BONE MARROW BIOPSY | HISTOPATHLOGY | BONE MARROW TISSUE SPECIMEN |
| BGHP 303 | BONE MARROW Aspirate examination | HISTOPATHLOGY | 2mL Bone Marrow in EDTA |
| BGHP 304 | BONE MARROW smear Iron stain | Staining & MS | 2mL Bone Marrow in EDTA |
| BGHP 305 |
BIOPSY - LARGE SPECIMEN Hysterectomy with salpingo-oophorectomy, ovarian cysts, non- malignant excisions of thyroid, kidney, testes, intestines, lymph node dissections, hepatic resections for metastases |
HISTOPATHLOGY | F F TISSUE / F F P E TISSUE |
| BGHP 306 |
BIOPSY - MEDIUM SPECIMEN simple hysterectomy, placenta, gal l bladder, breast lumpectomies and reductions, prostate and bladder chippings, skin excisions for cancer, brain |
HISTOPATHLOGY | F F TISSUE / F F P E TISSUE |
| BGHP 307 |
BIOPSY - SMALL SPECIMEN endometrial and cervical biopsies, endoscopic biopsies, trucut biopsies, apendix, fallopian tubes, products of conception, small incision/excision biopsies |
HISTOPATHLOGY | F F TISSUE / F F P E TISSUE |
| BGHP 308 |
BIOPSY-EXTRA LARGE SPECIMEN (radical excisions for cancers) |
HISTOPATHLOGY | F F TISSUE / F F P E TISSUE |
| BGHP 309 |
BIOPSY-SECOND OPINION slide and block for review (1 block) |
MS Interpretation | F F TISSUE / F F P E TISSUE |
| BGHP 310 | BIOPSY- PROSTRATE – NEEDLE | HISTOPATHLOGY | F F TISSUE / F F P E TISSUE |
| BGHP 311 | BIOPSY- LIVER – NEEDLE | HISTOPATHLOGY | F F TISSUE / F F P E TISSUE |
| BGHP 312 | BIOPSY- RENAL | HISTOPATHLOGY | F F TISSUE / F F P E TISSUE |
| BGHP 313 | BIOPSY - SKIN | Tissue process & staining | F F TISSUE / F F P E TISSUE |
| BGHP 314 |
BIOPSY-SECOND OPINION block for review (upto 4 blocks) |
MS Interpretation | F F P E TISSUE BLOCK |
| BGHP 315 |
BIOPSY-SECOND OPINION block for review (more than 4 blocks) |
MS Interpretation | F F P E TISSUE BLOCK |
| BGHP 316 |
BIOPSY-SECOND OPINION slide for review (1 slide) |
MS Interpretation | SLIDES |
| BGHP 317 |
BIOPSY-SECOND OPINION slides for review (upto 4 slide) |
MS Interpretation | SLIDES |
| BGHP 318 |
BIOPSY-SECOND OPINION slide for review (more than 4 slides) |
MS Interpretation | SLIDES |
| BGHP 319 |
IHC - INDIVIDAUL MARKERS AFP, ALK-1, BCL-2 , BCL-6, BETA CATENIN, BHCG, CALDESMON, CALRETININ, CALCITONIN, CATHEPSIN-D, CD1A, CD3, CD4, CD5, CD7, CD8, CD10, CD15, CD21, CD20, CD23, CD28, CD30, CD31,CD34, CD43, CD44, CD45, CD56, CD57, CD63, CD68, CD79A, CD99 (MIC-2), CD117 (C-KIT), CD138, CDK4, CDX2, CEA, CHROMOGRANIN, CK, CK -7, CK-18, CK-19, CK 5/6, CK -20, CYCLIN D1, DESMIN, DOG1, EBV (LMP), E-CADHERIN, EGFR, EP-CAM-EP155, EMA, EPITHELIAL ANTIGEN (BER EP4), ER, ERG, FLI1, GCDFP15, GATA-3, GFAP, GIST, GLYPICAN3, HEP PAR 1, HSA, HER2NEU, HMB 45, HMWCK, IDH1, INHIBIN, KAPPA, KI67, LAMBDA, MAMMOGLOBULIN, MELAN-A, MLH1, MLH2, MLH3, MLH4, MPO, MSH2, MSH6, MUM1, MYOGENIN, NAPSIN-A, NKX2.2, NKX3.5, NSE, OCT 2, P40, P504S, P53, P63, PANCYTOKERATIN, PAX5, PAX8, PLAP, PMS2, PR, PSA, S100, SMA, SOX2, SOX10, SYNAPTOPHYSIN, TDT, THYROGLOBULIN, TTF-1, VIMENTIN, WT-1, |
IHC | F F P E TISSUE BLOCK |
| BGHP 320 |
SPECIAL STAINS– Each Stain ( Reticulin, perls, PAS, Alcian Blue, GMS, Masson’s Trichome, ZN, Fite farraco, EVG) |
IHC | F F P E TISSUE BLOCK |
| BGHP 321 | IHC – Breast hormone panel-1 ER, PR | IHC | F F P E TISSUE BLOCK |
| BGHP 322 | IHC – Breast hormone panel-1 ER, PR, HER2NEU | IHC | F F P E TISSUE BLOCK |
| BGHP 323 |
IHC – Breast Prognostic panel ER, PR, HER2 NEU, KI67 |
IHC | F F P E TISSUE BLOCK |
| BGHP 324 | IHC – CNS NEOPLASMS - GFAP, EMA, GFAP, SYNAPTOPHYSIN, S-100, CD3, CD20, CYTOKEATIN | IHC | F F TISSUE / F F P E TISSUE BLOCK |
| BGHP 325 |
IHC – DIFFUSE LARGE CELL LYMPHOMA PANEL CD 3, CD45, CD20, CD30, Ki67 |
IHC | F F TISSUE / F F P E TISSUE BLOCK |
| BGHP 326 |
IHC – DIFFUSE SMALL CELL LYMPHOMAPANEL CD3, CD5, CD10, CD20, CD23 |
IHC | F F TISSUE / F F P E TISSUE BLOCK |
| BGHP 327 | IHC – Final Diagnostic panel-1(Up to 5 markers) | IHC | F F TISSUE / F F P E TISSUE BLOCK |
| BGHP 328 | IHC – Final Diagnostic panel-2(Up to 8 markers) | IHC | F F TISSUE / F F P E TISSUE BLOCK |
| BGHP 329 | IHC – FOLLICULAR LYMPHOMA Vs REACTIVE HYPERPLASIA PANEL- CD3, CD20, bcl-2 | IHC | F F TISSUE / F F P E TISSUE BLOCK |
| BGHP 330 |
IHC – Lymphoma panel (Hodgkin's Panel) LCA, CD30, CD15,EBV,CD20,PAX5, CD5 |
IHC | F F TISSUE / F F P E TISSUE BLOCK |
| BGHP 331 | IHC – Lymphoma panel (Non Hodgkin's Panel)LCA, CD10, CD20, PAX5, CD5, CD3, CD23, CyclinD1, Bcl2, OCT2, BOB1 | IHC | F F TISSUE / F F P E TISSUE BLOCK |
| BGHP 332 |
IHC – Mesothelioma panel ( Ber-EP4, CEA, Calaretin, WT1) |
IHC | F F TISSUE / F F P E TISSUE BLOCK |
| BGHP 333 |
IHC – Microsatellite Instability Panel for Colorectal Carcinoma (MLH -1, MSH-2, MSH-6, PMS-2) |
IHC | F F TISSUE / F F P E TISSUE BLOCK |
| BGHP 334 |
IHC – Myleoma / Plasmacyto panel LCA, CD20, CD138,KAPPA, LAMBDA, KI67 |
IHC | F F TISSUE / F F P E TISSUE BLOCK |
| BGHP 335 |
IHC - Pitituary Panel (Prolactin, Growth Hormone, LH, PCK,KI67) |
IHC | F F TISSUE / F F P E TISSUE BLOCK |
| BGHP 336 | IHC - SARCOMA TYPING PANEL - Desmin, Vimentin, S100, Smooth Muscle Actin, CD 31, CD34 | IHC | F F TISSUE / F F P E TISSUE BLOCK |
Diagnostics Test Categories
Click on the category to view Test Types!